Biotronik today shared preclinical results for its LivIQ leadless pacemaker system at Heart Rhythm Society (HRS) 2026 in ...
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...
Biotronik is looking to get the FDA's approval for a line of MRI-safe pacemakers--courtesy of Biotronik The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate ...
LAKE OSWEGO, Ore., Aug. 29, 2023 /PRNewswire/ -- BIOTRONIK, a leader in implantable medical device technology, today announced its first US implantation of the new Amvia Edge pacemaker. The procedure ...
This pacemaker will send an SMS to the mobile phone of the treating cardiologist, informing him of his patients’ heart failures just minutes after he’s gotten hammered on the golf course. Fortunately, ...
BIOTRONIK has unveiled its brand new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps) following CE Mark approval in Europe. These devices feature BIOTRONIK’s ProMRI ...
LAKE OSWEGO, Ore.-- (BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has granted approval for its ...
BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of high quality products for vascular intervention, implantable cardiac pacemakers and defibrillators, and the pioneer of wireless remote ...
BERLIN, March 24, 2026 /PRNewswire/ -- BIOTRONIK today announced the initiation of its global pivotal study evaluating the LivIQ leadless pacemaker system. This next-generation single‑device solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results